New search | Conferencedetail
Print view

BCMA Targeted Therapies

Evvnt Promotion / evvnt
21.06.2021 - 23.06.2021  Online
Time: 09:00 - 16:00
Conference themes
Targeting BCMA with therapeutics such as ADCs, bispecific T-cell engagers (BiTEs) and CAR-T therapies within Multiple Myeloma has huge potential. The race for an approval within the crowded BCMA space has been hotly contested in recent years, and despite GSK's ADC, Blenrep, gaining approval in 2020 first, BCMA-targeted CAR-T and BiTe therapies continue to find their place.
Professional congress organizer (PCO)
Hanson Wade
Speakers: Adam Cohen, Assistant Professor - Medicine, University of Pennsylvania, Andreas Pahl, Chied Scientific Officer, Heidelbeg Pharma, David DiLillo, Assoc. Director, Immuno-Oncology, Regeneron and more.

Enquiries and Registration:
Mr. Customer Service
General Medicine
Congress fees
USD 1799.0 - USD 3237.0
Participants expected
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

European Health Forum GasteinÖsterreichisches Rotes KreuzHelix - Forschung & Beratung WienÖsterreichische Gesellschaft für Public HealthAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAlumni Club Medizinische Universität WienAMREF - African Medical and Research FoundationAnästhesie in Entwicklungsländern e. V.